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ABSTRACT
INTRODUCTION
Hypertension is the most common chronic 
systemic disease in adults, and its prevalence tends 
to rise with age. As the number of hypertensive 
patients increases, it is expected to encounter 
more of these patients in dental practice29. Local 
anesthesia is an important concern in these patients 
as the anesthetic solution may cause serious 
complications.
Vasoconstrictors present many advantages 
and can be safely used for most patients treated 
by dentists. However, the benefits they provide 
are sometimes outweighed by potential risks of 
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Objective: Local anesthetic solutions with vasoconstrictors are not contraindicated in hypertensive patients, but due to their hemodynamic effects, local anesthetics without 
vasoconstrictors are mainly preferred by the clinicians. The aim of this study was to compare 
hemodynamic effects of three different local anesthetics without vasoconstrictors during 
tooth extraction in hypertensive patients. Material and Methods: Sixty-five mandibular 
molars and premolars were extracted in 60 hypertensive patients (29 females and 31 males; 
mean age: 66.95 ± 10.87 years; range: 38 to 86 years old). Inferior alveolar and buccal 
nerve blocks were performed with 2% lidocaine hydrochloride (HCl), 2% prilocaine HCl or 
3% mepivacaine HCl without vasoconstrictor. Hemodynamic parameters namely systolic 
blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart 
rate (HR), saturation rate (SR), rate pressure product (RPP) and pressure rate quotient 
(PRQ) were investigated before and at different intervals after anesthetic injection. Results: 
The hemodynamic effects of the three agents were similar to each other, although some 
significance was observed for DBP, MAP, RPP and PRQ values in the lidocaine, prilocaine 
and mepivacaine groups. Conclusion: Lidocaine, prilocaine and mepivacaine solutions 
without vasoconstrictor can be safely used in hypertensive patients. It is advisable that 
dental practitioners select anesthetic solutions for hypertensive patients considering their 
cardiovascular effects in order to provide patient comfort and safety. 
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extraction.
serious medical complications, especially in patients 
with cardiovascular disorders or other systemic 
conditions20,28. Life-threatening complications 
due to the sudden and dramatic increase in 
blood pressure (BP) can occur during dental 
procedures in hypertensive patients. Although it 
is stated in the literature that local anesthetics 
with vasoconstrictors can be safely used during 
oral surgery in hypertensive patients21, there are 
still some controversies about this subject12,14. 
It has been reported that the use of anesthetic 
solutions without vasoconstrictors increase the 
risk of hypertensive crisis due to the potential pain 
caused by insufficient intraoperative anesthesia24,25. 
Most clinicians prefer using local anesthetics 
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without vasoconstrictors in hypertensive patients 
due to the negative effects of vasoconstrictors on 
cardiovascular system. Therefore, hemodynamic 
aspects, like BP or heart rate (HR), in hypertensive 
patients come into prominence.
In addition to HR and BP, myocardial ischemia 
is also important in hypertensive patients. Rate 
pressure product (RPP) and pressure rate quotient 
(PRQ) are described as the possible predictors of 
myocardial oxygen consumption and subsequent 
ischemia. RPP is defined as the product of systolic 
BP (SBP) and the HR, and PRQ is defined as the 
mean arterial pressure (MAP) divided by the 
HR8,11,19. Significant values suggested for RPP range 
from 12,000 to 20,000 to indicate ischemia and over 
20,000 to indicate angina pectoris. It must be noted 
that 75% of all episodes of myocardial ischemia is 
silent and develops without anginal symptoms. For 
this reason, a RPP of 12,000 seems to provide a 
reasonable target value when monitoring ischemia. 
The target value for PRQ has been determined to be 
less than 1.08. Previous studies have searched the 
hemodynamic effects of vasoconstrictor containing 
local anesthetic solutions1,4,12; and such studies 
for plain solutions are also few6,9,17,26. Therefore, 
the purpose of this study was to compare the 
hemodynamic effects of three different anesthetic 
solutions without vasoconstrictors during tooth 
extraction in hypertensive patients.
MATERIAL AND METhODS
This study was performed in 70 consecutive 
Turkish hypertensive patients referred to the 
Department of Oral and Maxillofacial Surgery of 
the Faculty of Dentistry of Yeditepe University, for 
mandibular posterior tooth extraction. The normal 
range of BP was defined as systolic recording less 
than 140 mmHg and a diastolic recording of less 
than 90 mmHg. Patients who were diagnosed 
as hypertensive and under routine control by a 
medical practitioner were included in the study. 
In order to decrease effects of antihypertensive 
drugs on cardiovascular parameters, patients were 
selected from those who only use Ca++ channel-
blockers and beta-blockers. Participants were given 
detailed information about the study and informed 
consent was obtained. The same oral surgeon 
performed the tooth extractions. Sixty-five teeth 
were extracted under local anesthesia by blocking 
inferior alveolar (IAN) and buccal nerves and 1.5 
mL solution was used for IAN block and 0.5 mL for 
buccal nerve block. Anesthesia was achieved either 
by lidocaine HCl 2% (Jetokain Simplex® ampoule, 
ADeKA, Istanbul, Turkey) or prilocaine HCl 2% 
(Citanest® flacon, Astra Zeneca, Istanbul, Turkey) 
or mepivacaine HCl 3% (Isocain® ampoule, Novocol 
Pharmaceutical of Canada, Ontario, Canada) 
without vasoconstrictors. Patients with SBP higher 
than 160 mmHg and DBP higher than 95 mmHg 
and with any other current medical problems were 
excluded from the study.
All patients were monitored at different 
evaluation periods. SBP, DBP, MAP, HR, pulse 
oxymeter oxygen saturation (SR), RPP and PRQ 
were recorded as the initial (baseline) hemodynamic 
values. Then, patients rest for 20 min and same 
measurements were repeated 3 min before 
injection. The local anesthesia was administered 
by inferior alveolar and buccal nerve blocks. 
An electrocardiogram monitor (Datex Ohmede 
Cardiocap 5, Helsinki, Finland), a pulse oxymeter, 
and a BP cuff were used to monitor cardiac and 
hemodynamic changes before and after delivery of 
local anesthetic. RPP was calculated by multiplying 
HR and SBP. RPQ was obtained by dividing MAP by 
HR. A standard mathematical equation was used 
to calculate MAP value [MAP=(2DBP+SBP)/3]13. All 
hemodynamic values were recorded at initial, 3 min 
before the injection and every 3 min after anesthetic 
injection up to the 15th min. Follow-up periods 
were determined according to Knoll-Köhler, et al.15 
(1989) and Fernieini, et al.10 (2001). The monitoring 
procedures were standardized by keeping the 
cuff on the patient’s left arm, in supine position. 
Extraction period was defined as the duration from 
initiation of the injection to accomplishing the tooth 
extraction.
Statistical tests were performed using NCSS 
2007 program for Windows. The following tests were 
used: one-way ANOVA for descriptive statistical 
methods (mean and standard deviation) and for 
repetitive analysis of multiple groups; Newman 
Keuls multiple-comparison test for comparison 
of the subgroups; one-way ANOVA for intergroup 
comparisons; Tukey’s multiple comparison test for 
comparison of the subgroups; and chi-square tests 
for comparison of qualitative data. P values ≤ 0.05 
was considered as significant.
RESULTS
Seventy consecutive hypertension patients were 
enrolled for the study. Three patients were excluded 
as additional anesthetic solution was injected due to 
inadequate anesthesia; four patients were excluded 
because they declared during the study that they 
were using other systemic drugs; three patients 
were excluded because they have excessive dental 
anxiety. This way, 65 teeth (57 molars and 8 second 
premolars) were extracted due to periodontal 
problems, extensive caries or prosthetic reasons 
from 60 hypertensive patients (29 females and 31 
males; mean age: 66.95 ± 10.87 years; range: 
38 to 86 years old). Chi-square test was used to 
investigate the demographic data and no significant 
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differences were found among the groups with 
respect to age (p=0.069), gender (p=0.935), type 
of extracted tooth (p=0.597) and extraction period 
(p= 0.169). Twenty-one teeth were extracted with 
lidocaine 2% HCl, 22 teeth were extracted with 2% 
prilocaine HCl and 22 teeth were extracted with 3% 
mepivacaine HCl (Table 1).
There was no significant difference (p>0.05) 
among the three groups and subgroups (lidocaine, 
prilocaine and mepivacaine groups separately) for 
the mean SBP values during the observation periods 
(Table 2). After the delivery of local anesthesia, the 
SBP increased in the prilocaine and mepivacaine 
groups, but this increase was not statistically 
significant (p>0.05). Significant differences 
were noted for mean DBP change in lidocaine 
(p=0.025) and prilocaine groups (p=0.016) during 
the observation periods (Table 2). There was no 
significant difference (p>0.05) among the three 
groups in mean MAP values during the observation 
periods; however, significant differences were noted 
for the mean MAP change in lidocaine (p=0.013) 
and prilocaine groups (p=0.001) during the 
observation periods (Table 2).
Table 3 shows HR and SR measurements. 
Significant differences were determined in the mean 
HR during injection, at the 3rd min after injection 
and at the 12th min after the injection among the 
three groups (p<0.05). Significant differences were 
also noted for the mean HR change in the lidocaine 
(p=0.019) and mepivacaine groups (p=0.004) 
during the observation periods (Table 3). There 
was no significant differences (p>0.05) among the 
three groups and subgroups for the mean SR values 
during observation periods (Table 3).
Table 4 shows RPP and PRQ measurements. 
For RPP, 63/140 (45%) measurements in the 
lidocaine group, 67/140 (47.8%) measurements 
Anesthetic 
Solution
Initial 3 min before 
injection
3 min after 
injection
6 min after 
injection
9 min after 
injection
12 min after 
injection
15 min after 
injection
p
SBP
(mmHg)
Lidocaine 
HCl
147.65±11.71 147.35±15.02 144.5±15.14 144.15±15.4 145.55±19.24 139.9±13.65 141.65±14.18 0.139
Prilocaine 
HCl
145.95±14.93 151±21.13 144.95±21.83 144.75±18.88 145.5±16.94 141.15±19.44 140.25±17.31 0.098
Mepivacaine 
HCl
151.3±12.07 154.3±12.4 151.55±14.67 153.55±12.48 152.05±13.3 150.25±14.1 146.9±13.76 0.344
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
DBP
(mmHg)
Lidocaine 
HCl
83.5±10.23 86.1±11.25 83.1±11.14 84.85±11.95 86.3±11.13 80.65±9.13 82.25±10.56 0.025
Prilocaine 
HCl
85.3±6.99 89.7±10.67 86.35±10.87 87.95±10.1 85.8±11.33 84.3±11.28 82.2±13.05 0.016
Mepivacaine 
HCl
86±7.83 86.4±10.58 86.25±10.96 89.15±13.31 88±13.78 86.65±9.84 86.9±11.97 0.758
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
MAP 
(mmHg)
Lidocaine 
HCl
106.65±10.28 108.75±10.79 106.75±12.48 107.25±10.67 106.65±12.03 100.9±10.45 102.55±11.56 0.013
Prilocaine 
HCl
106.7±11.91 113.6±15.31 110.3±13.95 110.1±13.12 108.3±13.9 105.45±13.84 103.1±14.03 0.001
Mepivacaine 
HCl
112.15±10.55 114.05±9.69 109.35±10.52 114.1±12.57 112.6±12.98 111.3±10.74 109.8±11.85 0.063
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
         
Table 2- Mean systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) in the 
lidocaine, prilocaine and mepivacaine groups. Data are present as mean ± standard deviation
Bold numbers indicate significant changes for intragroup comparison.
Lidocaine 
HCl
Prilocaine 
HCl
Mepivacaine 
HCl
p
Gender Male 11 10 10 χ²: 0.13 0.935
Female 9 10 10
Mean age(yrs) Male 59.88±7.8 67.9±9.24 69±8.09 F:2,95 0.069
Female 70.27±7.77 59.6±12.86 74±9.7
Mean 65.6±9.34 63.75±11.94 71.5±9.28
Teeth extracted Molar 20 18 19 χ²: 2.76 0.597
Premolar 1 4 3
Extraction period (Min) 13.91±8.13 10.14±4.22 10.56±4.92 F:1.84 0.169
Table 1- Distribution of the patients, teeth extracted and extraction periods
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in the prilocaine group and 55/140 (39.2%) 
measurements in the mepivacaine group ranged 
from 12,000 to 20,000. There were no significant 
differences (p>0.05) among the three groups 
for the mean RPP values during the observation 
periods; however significant changes were noted 
in the lidocaine (p=0.017) and prilocaine groups 
(p=0.049) during the observation periods (Table 
4). For PRQ, 6/140 (4.2%) measurements were 
<1 the in lidocaine group and 10/140 (7.1%) 
measurements were <1 in the prilocaine group. 
All PRQ measurements (100%) in the mepivacaine 
group were ≥1.
Significant differences (p<0.05) were found 
among the three groups at baseline (initial), 3 
min before the injection, and 3, 6, 9, 12 and 15 
min after the injection for the mean PRQ values . 
Significant changes were also noted in the lidocaine 
(p=0.029) and prilocaine groups (p=0.013) during 
the observation periods (Table 4).
The results of the one-way ANOVA, Tukey’s 
post-hoc multiple-comparison test, repeated one-
way ANOVA and Newman Keuls post-hoc multiple 
comparison tests  are shown in Tables 2-4.
DISCUSSION
Most studies on the hemodynamic effects of local 
anesthetic solutions were done with vasoconstrictor 
containing solutions. However, these effects can be 
due not only to vasoconstrictor but to the agent 
itself22. There are few researches on the effects   of 
plain solutions; therefore this study may help dental 
practitioners to have some information about the 
hemodynamic effects of the most commonly used 
anesthetic solutions for hypertensive patients.
The major concern in dentistry is perioperative 
hypertension crisis in hypertensive patients. As 
hypertension can bring about complications such 
as paralysis, heart and renal problems, and acute 
medical problems, hypertensive patients constitute 
an important risk group in dental treatment.
Meiller, et al.23 (1983) in a study on normotensive 
and hypertensive patients, determined that during 
local anesthesia and tooth extraction that BP 
increased continually, though without statistical 
significance. In the present study, SBP did not 
show statistically significant differences among the 
groups, but significant changes were observed in 
the lidocaine and prilocaine groups in DBP and MAP, 
though not in increasing fashion. This may be due 
to the agents themselves or to the dental anxiety 
felt by the patients.
Holm, et al.14 (2006) reported hypertensive crisis 
as SBP of at least 250 mmHg, DBP of at least 130 
mmHg, or both. In the present study, none of the 
patients presented such high SBP or DBP rates, and 
no cardiovascular complications occurred during 
tooth extractions.
The lack of a control group in the present study 
Anesthetic 
Solution
Initial 3 min before 
injection
3 min after 
injection
6 min after 
injection
9 min after 
injection
12 min after 
injection
15 min after 
injection
p
HR(Beat/min) Lidocaine HCl 83.8±11.51 82.7±10.32 80.75±11.92 80.45±10.08 80.4±10.62 81.65±11.69 80.25±9.14 0.019
Prilocaine HCl 84.3±14.12 82.6±13.87 83.7±14.19 82±11.7 81.9±13.3 81.75±12.66 80.85±14.47 0.435
Mepivacaine HCl 76.75±12.68 74.75±13.74 72.7±12.42 74.35±13.14 72.8±14.35 72.05±13.62 72±13.96 0.004
 p >0.05 0.039 0.026 >0.05 >0.05 0.027 >0.05  
SR (%) Lidocaine HCl 97±2.27 96.45±1.98 96.55±1.79 95.9±1.83 96.35±1.98 95.4±2.87 95.65±1.78 0.231
Prilocaine HCl 96.65±1.81 97±2.15 96.8±1.98 96.15±2.08 95.6±4.81 96.25±1.74 95.6±2.37 0.308
Mepivacaine HCl 96.1±2.59 96.15±1.87 96.2±1.93 95.7±2.12 96.2±2.83 96.05±1.63 95.9±1.8 0.957
 p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05  
Bold numbers indicate significant changes for intragroup comparison.
Table 3- Mean heart rate (HR) and saturation sate (SR) in the lidocaine, prilocaine and mepivacaine groups
Anesthetic 
Solution
Initial 3 min before 
injection
3 min after 
injection
6 min after 
injection
9 min after 
injection
12 min after 
injection
15 min after 
injection
p
RPP Lidocaine HCl 12315.8±2224.75 12259.55±2214.23 11645.3±1982.12 11596.4±1923.24 11724.95±2394.75 11324.9±1841.21 11314.85±1908.88 0.017
Prilocaine HCl 12336.05±2614.1 12489.1±3081.66 12331.75±2754.09 11980.1±2477.59 11981.55±2716.08 11568.95±2672.47 11357.05±2676.52 0.049
Mepivacaine 
HCl
11736.05±2510.84 11427.45±2622.49 11071.75±2426.41 11687.05±2628.97 11247.75±2731.14 11220.75±2760.02 10953±2872.82 0.145
P >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
PRQ Lidocaine HCl 1.29±0.18 1.33±0.2 1.35±0.28 1.35±0.2 1.34±0.22 1.25±0.23 1.3±0.22 0.029
Prilocaine HCl 1.35±0.3 1.41±0.31 1.35±0.27 1.47±0.32 1.44±0.31 1.31±0.24 1.32±0.29 0.013
Mepivacaine 
HCl
1.48±0.21 1.6±0.32 1.54±0.29 1.58±0.36 1.6±0.37 1.59±0.31 1.57±0.3 0.143
P 0,033 0.011 0.048 0.049 0.032 0.0001 0.004
         Bold numbers indicate significant changes for intragroup comparison.
Table 4- Mean RPP and PRQ in the lidocaine, prilocaine and mepivacaine groups
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consisting of epinephrine-containing local anesthetic 
to verify the effect of epinephrine on hemodynamic 
values in hypertensive patients may be open to 
criticism. However, as our clinical protocol for 
hypertensive patients does not include the use of 
epinephrine-containing anesthetics, it would be 
unethical to form such a comparison group in this 
study. In addition, it was not the study purpose 
to evaluate correlations between hemodynamic 
parameters and age, gender or extraction periods, 
which may be investigated in another study.
The present finding that HR decreased 
significantly in the lidocaine and mepivacaine 
groups is similar to the findings of earlier studies27,32. 
Paramaesvaran and Kingon27 (1994) found that 
33 out of the 35 patients who received local 
infiltrations had a decrease in the HR during or after 
anesthesia. Yokobayashi, et al.32 (1977) found that 
administration of local anesthesia lowered the HR, 
and local infiltration resulted in a more significant 
effect than block anesthesia. Meanwhile Liau, et al.18 
(2008), reported an increase in the HR and the BP 
during local anesthesia. Bradycardia due to local 
anesthesia may be related with the effect of local 
anesthetic itself. Van Rooij, et al.30 (2004) reported 
that lidocaine may develop bradycardia in neonates. 
An animal study also demonstrated that lidocaine 
may decrease the HR2 and mepivacaine can also 
cause bradycardia3. It has been reported that 
abnormal electrocardiography changes may occur 
during local anesthesia delivery and oral surgery 
in 15 %-37.5 % of the patients5,7. The differences 
among the studies may have been due to different 
study populations or to the dose of anesthetic 
used. Various antihypertensive drugs have different 
effects on hemodynamic parameters such as 
vasodilatation, decreasing peripheral resistance, 
decreasing BP and bradycardia. Therefore, in order 
to provide standardization, patients using Ca++ 
channel-blockers and beta-blockers only were 
included in the study.
There were no significant changes in SR 
rates among the groups. In the literature, it is 
reported that prilocaine and lidocaine may cause 
methemoglobinemia16,31. Liau, et al.18 (2008) stated 
that SR changes correlated with pain on injection 
before local anesthesia delivery, but not during 
the postinjection period, and the extent to this 
correlation was attributable to factors influencing 
the perception of pain, such as anxiety and past 
dental experience. We did not evaluate the stress 
and dental anxiety secondary to injection and 
tooth extraction in this study. Further studies 
are necessary to include the effects of stress and 
anxiety on the relationship between anesthetic 
injection and hemodynamic changes.
Myocardial ischemia occurs when the oxygen 
demands of the myocardium exceeds the supply. 
Demand is affected by the HR, preload, afterload 
and contractility. The clinical manifestations are 
quite variable, with many patients free of symptoms 
whereas others experience varying degrees of 
angina pectoris8. In the present study, significant 
differences in RPP and PRQ values were noted 
between the lidocaine and prilocaine groups. 
However, clinical signs and symptoms of clinical 
disturbance or angina attack were observed in any 
of the patients.
Local anesthesia is commonly used in dental 
practice. Hypertensive patients constitute a large 
number among patients with systemic diseases. 
Selection of a proper anesthetic solution will provide 
patient safety and satisfaction. Further evaluation 
of the efficiency and safety of different anesthetic 
solutions in patients with systemic diseases is 
advisable.
CONCLUSION
It may be concluded that the hemodynamic 
effects of the three local anesthetic solutions 
evaluated in this study were similar to each 
other, and they could be safely used during tooth 
extractions in hypertensive patients, though 
significant variations may arise probably due to the 
anesthetic properties.
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